Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
eli lilly
fda
indiana blog main
indiana top stories
lasmiditan
3
×
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
triptans
amgen
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
migraine
migraine research foundation
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abalos therapeutics
acetonid
achillion pharmaceuticals
aglios therapeutics
What
new
3
×
approval
decades
drug
drugs
fda
migraine
pharmaceutical
won
acute
addresses
arguments
bails
big
bio
brand
bridgebio
capital
car
causes
class
commercialized
companies
competitors
condition
develop
eli
emerges
firm
friday
giant
giving
grab
headlines
ichnos
invest
lasmiditan
life
lilly
lilly’s
Language
unset
Current search:
lasmiditan
×
new
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
